AQR Capital Management
DERM icon

AQR Capital Management’s Journey Medical DERM Stock Holding History

AQR Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,270
Closed -$395K – 3762
2025
Q4 		$395K Buy
51,270
+436
+0.9% +$3.42K ﹤0.01% 3036
2025
Q3 		$362K Buy
+50,834
New +$369K ﹤0.01% 2982

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management's DERM Position: Q1 2026 in Review

AQR Capital Management sold out of Journey Medical (DERM) in Q1 2026, closing a stake of 51,270 shares — an estimated $395K sold.

AQR Capital Management first reported a position in DERM in Q3 2025 and held it in 2 quarters. The position peaked at $395K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • AQR Capital Management reported no remaining Journey Medical position as of Q1 2026 after selling out during the quarter.
  • AQR Capital Management sold 51,270 Journey Medical shares in Q1 2026, an estimated $395K.
  • AQR Capital Management first reported a position in Journey Medical in Q3 2025 and held it in 2 quarters.
  • AQR Capital Management's Journey Medical position peaked at $395K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.